ICON plc, a world-leading clinical research organization, will release its financial results for the second quarter of 2026 after the market closes on Wednesday, July 29, 2026. The company will hold a conference call and webcast to discuss its financial results and performance on Thursday, July 30, 2026, at 8:00am ET. The announcement provides investors with a specific timeline to assess the company's operational progress and financial health for the quarter.

Any changes to the event schedule and links to the live webcasts will be posted on the Investor section of the company's website under "Events". A webcast replay of the conference call will be available approximately one hour following the conclusion of the call, allowing stakeholders to access the discussion at their convenience.

Key Event Details

Company Profile

ICON plc provides integrated consulting, clinical development, commercialization, and post-marketing solutions to pharmaceutical, biotechnology, medical device, government, and public health organizations worldwide. Headquartered in Dublin, Ireland, the company employed approximately 40,350 employees across 97 locations in 55 countries as of March 31, 2026.

Moore Law PLLC is investigating ICON plc regarding potential issues concerning the company's accounting practices and internal controls. The investigation follows a press release issued by ICON on February 12, 2026, which detailed an ongoing internal probe initiated by its Audit Committee. The law firm is encouraging affected shareholders to come forward to discuss potential legal remedies.

Internal Investigation and Disclosure

ICON announced on February 12, 2026, that the Audit Committee of the Board of Directors launched an internal investigation in late October 2025. The probe focuses on certain accounting practices and controls after concerns were reported to the Audit Committee through company management. ICON stated in the release that it intends to release its fourth quarter and full year 2025 earnings results on or prior to April 30, 2026.

Market Reaction

Following the disclosure of the investigation, ICON ordinary shares plummeted in intraday trading on February 12, 2026. The decline reflects investor concerns regarding the potential financial and governance implications of the accounting review.

Shareholder Options

Shareholders who own ICON plc securities are advised to contact Fletcher Moore at Moore Law PLLC. The firm indicates that investors may be able to seek monetary damages, corporate governance reforms, reimbursement to the company, and a court-approved incentive award. All representation is conducted on a contingency fee basis, meaning shareholders pay no fees or expenses.